Due to limitations in time and space, only the classic treatment drugs and approaches used in the history of HCC systemic therapy were included, and many other topics, such as TME subtyping, MAIT cells, bispecific T-cell engagers (135, 136), tumor vaccines, and immune therapies beyond PD-L1 (137), were not discussed. Here, CD274 is linked to hepatocellular carcinoma.